10,000 Shares in Protagonist Therapeutics, Inc. $PTGX Purchased by Dymon Asia Capital Singapore PTE. LTD.
Dymon Asia Capital Singapore PTE. LTD. acquired a new stake in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 10,000 shares of the company’s stock, valued at approximately $873,000. A number of other hedge […]
14 Jun 09:16 · The Markets Daily